Gastroenterología y Hepatología (English Edition)

Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease—EXVEDOCOL Viviana Parra; Sandra Cifuentes; Sandra Avendaño; Enrique Ponce de León; Cristian Florez; Gustavo Reyes; Fabian Puentes; Manuel Ballesteros; Edilberto Nuñez; Federico Gómez; Juan Ricardo Márquez;

Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;

EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti-tumor necrosis factor-α as first- or second-line biologic treatment among patients with ulcerative colitis Francesc Casellas; Ana Gutiérrez-Casbas; Cristina Rodríguez; Javier P. Gisbert; Sabino Riestra; Claudia Herrera de Guise; Isabel Vera-Mendoza; Pilar Martínez-Montiel; Sónia Bernardo; Isabel Medeiros; Jesús Aparicio; Ignacio Tagarro; Teresa Letosa-Abián; Carmen Montoto; Fernando Muñoz;